PRME (Prime Medicine Corp) סך נכסי הפעילות העסקית

This Prime Medicine, Inc. (PRME) price chart demonstrates total assets amounting to 264.04. The company's production facilities are equipped with DNA synthesis automation to eliminate laboratory downtime. The business relies on developing precision genome editing methods to combat hereditary pathologies. Therapeutic successes are achieved through close scientific symbiosis with academic centers and specialized institutes.

For Prime Medicine, Inc. (PRME), a leader in Prime Editing, aggregate resources determine the scale of R&D investment and the efficiency of capital management. The 264.04 metric, calculated inversely via ROA, combines equity and liabilities to capture the total value of controlled assets. By analyzing changes in balance sheet assets, an investor can assess management's financial stability and the potential for expanding the company's technological base.